ID   HRA
AC   CVCL_U986
DR   BTO; BTO_0004925
DR   Wikidata; Q54895212
RX   PubMed=3791243;
RX   PubMed=10381137;
RX   PubMed=12019149;
RX   PubMed=18720132;
CC   Population: Japanese.
CC   Doubling time: 15.6 hours (PubMed=3791243).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZE74 ! HR
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 8
//
RX   PubMed=3791243;
RA   Kikuchi Y., Kizawa I., Oomori K., Miyauchi M., Kita T., Sugita M.,
RA   Tenjin Y., Kato K.;
RT   "Establishment of a human ovarian cancer cell line capable of forming
RT   ascites in nude mice and effects of tranexamic acid on cell
RT   proliferation and ascites formation.";
RL   Cancer Res. 47:592-596(1987).
//
RX   PubMed=10381137; DOI=10.1016/S0304-3835(98)00270-5;
RA   Ohta H., Sakamoto H., Satoh K.;
RT   "In vitro effects of gonadotropin-releasing hormone (GnRH) analogue on
RT   cancer cell sensitivity to cis-platinum.";
RL   Cancer Lett. 134:111-118(1998).
//
RX   PubMed=12019149;
RA   Kajiyama H., Kikkawa F., Suzuki T., Shibata K., Ino K., Mizutani S.;
RT   "Prolonged survival and decreased invasive activity attributable to
RT   dipeptidyl peptidase IV overexpression in ovarian carcinoma.";
RL   Cancer Res. 62:2753-2757(2002).
//
RX   PubMed=18720132; DOI=10.1080/10717540802329183;
RA   Serikawa T., Kikuchi H., Oite T., Tanaka K.;
RT   "Enhancement of gene expression efficiency using cationic liposomes on
RT   ovarian cancer cells.";
RL   Drug Deliv. 15:523-529(2008).
//